Milan, InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation. The release of two new products for oncology that have no equals on the market – PCa GnRH Agonists Simulator and CTx NeutroSim – is going to accelerate the growth of this startup with offices in Italy, USA and the Netherlands. Counting on an international team of life sciences and IT experts, InSilicoTrials has found a unique way to leverage modeling & simulation, making this very complex and expensive technology easy to use and
The post InSilicoTrials releases two new state-of-the-art simulation tools for oncology appeared first on Pharma Mirror Magazine.
